Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Weicheng Guo became the CEO of Sihuan Pharmaceutical Holdings Group Ltd.
HONG KONG, Feb. 18, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to ...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today, we'll introduce the concept of the P/E ratio for those who are ...
Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group Ltd. has announced the market purchase of 5 million shares as part of its 2022 Share Award ...
HONG KONG, Oct. 20, 2020 /PRNewswire/ -- On 20 October 2020, Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group" ...
Sihuan Pharma (HK:0460) Annual Report This summary provides an overview of the most significant critical numbers from each of the Sihuan Pharma financial reports, including the Sihuan Pharmaceutical ...
Leading Chinese pharmaceutical company Sihuan Pharmaceutical announced March 11 that its application to register Tylerdipine Hydrochloride has been accepted by the Chinese State Food and Drug ...
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital. So it might be obvious that you need to consider debt, when ...
Find the Sihuan Bioeng A financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the Sihuan ...
Explore the HK:0460 financials. Find the Sihuan Pharma financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial ...
Drug set for launch in or before the first quarter of next year; Aims to target hospital market Dr. Che Fengsheng, Chairman and CEO of Sihuan Pharmaceutical, said, "Roxatidine has a high clinical ...
In 2014 Weicheng Guo was appointed CEO of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460). This analysis aims first to contrast CEO compensation with other companies that have similar market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results